New Delhi: Two days after expressing “some preliminary good news” on the efficacy of Oxford vaccine candidate developed by the University of Oxford with AstraZeneca Plc, India’s Serum Institute CEO Adar Poonawalla told NDTV on Wednesday that the first batch of 100 million doses should be available by the second or third quarter of 2021.
“If we don’t go for an emergency license, our trials should be over by December and then we can maybe launch it in India in January subject to the UK trial also being completed,” he was quoted as saying by the news channel.
According to a Bloomberg article, Oxford COVID vaccine “has produced a robust immune response in older adults and the elderly, those at highest risk of severe illness.”
Bhubaneswar: Chief Minister Mohan Charan Majhi on Tuesday informed about the central government's plans for…
Bhubaneswar: Amid a brouhaha over cracks detected on the ‘Meghanada Pacheri’ surrounding Shree Jatannath Temple…
New Delhi: In a recently released guidelines, the Department of Pension and Pensioners’ Welfare (DoPPW)…
Berhampur: After Bhubaneswar Commissionerate Police, Berhampur police have introduced body cameras for its personnel to…
New Delhi: The Supreme Court on Tuesday held that states are not empowered by the…
New Delhi: The central government has sent a notice to Wikipedia—which endorses itself as a…
Bhubaneswar: Four journalists from Odisha sustained critical injuries when as the SUV carrying them rammed…
Puri: Gajapati Maharaja Dibyasingha Deb on Tuesday said legal action would be initiated against International…